IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BAKHTAWAR USMAN

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1376167031
CMS profile
10825104
Location
WARRENVILLE, IL

General Payments · PY2021–2024

$4,573.14

  • Reported across 255 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,147.10

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Physician Assistant IL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,134.95 50
Education $12.15 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alkermes, Inc. $235.88 6
ITI, Inc. $175.72 11
Neurocrine BioSciences, Inc. $146.67 6
ABBVIE INC. $89.94 5
Vanda Pharmaceuticals Inc. $73.81 2
Lundbeck LLC $64.52 3
Supernus Pharmaceuticals, Inc. $56.95 3
Otsuka America Pharmaceutical, Inc. $46.62 2
Janssen Pharmaceuticals, Inc $40.87 2
IRONSHORE PHARMACEUTICALS INC. $39.72 2
Teva Pharmaceuticals USA, Inc. $38.40 2
Axsome Therapeutics, Inc. $27.35 1
IDORSIA PHARMACEUTICALS US INC $27.27 2
Corium, Inc. $26.42 1
Almatica Pharma Inc. $22.66 1
Takeda Pharmaceuticals U.S.A., Inc. $18.08 1
Tris Pharma Inc $16.22 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,517.54 95
PY2022 $1,349.52 81
PY2023 $558.98 28
PY2024 $1,147.10 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.08 01/31/2024 Food and Beverage Undisputed 01/23/2026 1108342483 CMS
ABBVIE INC. $22.13 02/28/2024 Food and Beverage Undisputed 01/23/2026 1108342485 CMS
ABBVIE INC. $20.25 03/13/2024 Food and Beverage Undisputed 01/23/2026 1108342487 CMS
ABBVIE INC. $19.57 05/29/2024 Food and Beverage Undisputed 01/23/2026 1108342489 CMS
ABBVIE INC. $13.91 09/18/2024 Food and Beverage Undisputed 01/23/2026 1108342491 CMS
Alkermes, Inc. $21.69 09/17/2024 Food and Beverage Undisputed 01/23/2026 1120612757 CMS
Alkermes, Inc. $102.73 10/02/2024 Food and Beverage Undisputed 01/23/2026 1120612759 CMS
Alkermes, Inc. $26.91 10/10/2024 Food and Beverage Undisputed 01/23/2026 1120612761 CMS
Alkermes, Inc. $30.16 10/22/2024 Food and Beverage Undisputed 01/23/2026 1120612763 CMS
Alkermes, Inc. $26.43 11/06/2024 Food and Beverage Undisputed 01/23/2026 1120612765 CMS
Alkermes, Inc. $27.96 12/10/2024 Food and Beverage Undisputed 01/23/2026 1120612767 CMS
Almatica Pharma LLC $22.66 09/23/2024 Food and Beverage Undisputed 01/23/2026 1137620697 CMS
Axsome Therapeutics, Inc. $27.35 02/21/2024 Food and Beverage Undisputed 01/23/2026 1148339889 CMS
Corium, LLC $26.42 10/29/2024 Food and Beverage Undisputed 01/23/2026 1100194634 CMS
IDORSIA PHARMACEUTICALS US INC $13.10 03/06/2024 Food and Beverage Undisputed 01/23/2026 1146769095 CMS
IDORSIA PHARMACEUTICALS US INC $14.17 05/01/2024 Food and Beverage Undisputed 01/23/2026 1146776948 CMS
IRONSHORE PHARMACEUTICALS INC. $17.38 02/06/2024 Food and Beverage Undisputed 01/23/2026 1146258823 CMS
IRONSHORE PHARMACEUTICALS INC. $22.34 09/20/2024 Food and Beverage Undisputed 01/23/2026 1146290086 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.22 01/10/2024 Food and Beverage Undisputed 01/23/2026 1143620255 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.71 01/10/2024 Food and Beverage Undisputed 01/23/2026 1143620257 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.85 02/20/2024 Food and Beverage Undisputed 01/23/2026 1143620259 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.35 02/20/2024 Food and Beverage Undisputed 01/23/2026 1143620261 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.98 03/27/2024 Food and Beverage Undisputed 01/23/2026 1143620263 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.69 04/15/2024 Food and Beverage Undisputed 01/23/2026 1143620265 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.15 05/22/2024 Education Undisputed 01/23/2026 1143620267 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.45 05/22/2024 Food and Beverage Undisputed 01/23/2026 1143620269 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.06 06/03/2024 Food and Beverage Undisputed 01/23/2026 1143620271 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.86 10/21/2024 Food and Beverage Undisputed 01/23/2026 1143620273 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.40 12/18/2024 Food and Beverage Undisputed 01/23/2026 1143620275 CMS
Janssen Pharmaceuticals, Inc $22.33 10/16/2024 Food and Beverage Undisputed 01/23/2026 1078014280 CMS
Janssen Pharmaceuticals, Inc $18.54 11/19/2024 Food and Beverage Undisputed 01/23/2026 1078014286 CMS
Lundbeck LLC $14.10 04/30/2024 Food and Beverage Undisputed 01/23/2026 1146101879 CMS
Lundbeck LLC $25.35 11/12/2024 Food and Beverage Undisputed 01/23/2026 1146101881 CMS
Lundbeck LLC $25.07 12/03/2024 Food and Beverage Undisputed 01/23/2026 1146101883 CMS
Neurocrine Biosciences, Inc. $6.59 02/14/2024 Food and Beverage Undisputed 01/23/2026 1151020102 CMS
Neurocrine Biosciences, Inc. $23.20 03/19/2024 Food and Beverage Undisputed 01/23/2026 1150963044 CMS
Neurocrine Biosciences, Inc. $26.20 09/24/2024 Food and Beverage Undisputed 01/23/2026 1150950729 CMS
Neurocrine Biosciences, Inc. $34.47 10/14/2024 Food and Beverage Undisputed 01/23/2026 1150932560 CMS
Neurocrine Biosciences, Inc. $28.94 10/30/2024 Food and Beverage Undisputed 01/23/2026 1150942299 CMS
Neurocrine Biosciences, Inc. $27.27 11/04/2024 Food and Beverage Undisputed 01/23/2026 1150947057 CMS
Otsuka America Pharmaceutical, Inc. $19.86 05/15/2024 Food and Beverage Undisputed 01/23/2026 1119205242 CMS
Otsuka America Pharmaceutical, Inc. $26.76 11/05/2024 Food and Beverage Undisputed 01/23/2026 1119205244 CMS
Supernus Pharmaceuticals, Inc. $23.42 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147894681 CMS
Supernus Pharmaceuticals, Inc. $13.58 02/27/2024 Food and Beverage Undisputed 01/23/2026 1147894677 CMS
Supernus Pharmaceuticals, Inc. $19.95 05/03/2024 Food and Beverage Undisputed 01/23/2026 1147894679 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.08 02/14/2024 Food and Beverage Undisputed 01/23/2026 1137837325 CMS
Teva Pharmaceuticals USA, Inc. $16.41 10/01/2024 Food and Beverage Undisputed 01/23/2026 1151567503 CMS
Teva Pharmaceuticals USA, Inc. $21.99 11/27/2024 Food and Beverage Undisputed 01/23/2026 1151567523 CMS
Tris Pharma Inc $16.22 12/30/2024 Food and Beverage Undisputed 01/23/2026 1147212587 CMS
Vanda Pharmaceuticals Inc. $39.25 12/02/2024 Food and Beverage Undisputed 01/23/2026 1133974406 CMS
Vanda Pharmaceuticals Inc. $34.56 12/20/2024 Food and Beverage Undisputed 01/23/2026 1133974408 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.